XML 51 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
6 Months Ended
Jun. 30, 2014
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 8. Stock-Based Compensation

We account for stock-based compensation in accordance with the provisions of FASB Accounting Standards Codification (“ASC”) topic 718, Compensation-Stock Compensation (“ASC 718”), which established accounting for stock-based awards exchanged for employee services. Stock-based compensation cost is measured at each grant date, based on the fair value of the award, and is recognized as expense over the employee’s requisite service period of the award. All of our stock compensation is accounted for as an equity instrument.
 
The following table summarizes compensation costs related to our stock-based awards (in thousands, except per share data):

 
 
Three Months Ended
June 30,
  
Six Months Ended
June 30,
 
 
 
2014
  
2013
  
2014
  
2013
 
 
        
Cost of revenue
 
$
5
  
$
5
  
$
10
  
$
11
 
Selling, general and administrative
  
245
   
291
   
489
   
575
 
Research and development
  
47
   
42
   
90
   
84
 
Total stock-based compensation
  
297
   
338
   
589
   
670
 
Tax effect on stock-based compensation
  
   
   
   
 
Net effect on net income (loss)
 
$
297
  
$
338
  
$
589
  
$
670
 
 
As of June 30, 2014, the unamortized compensation costs related to unvested stock options granted to employees under our stock option plan was approximately $1.2 million, net of estimated forfeitures of $78,000. These costs will be amortized on a straight-line basis over a weighted-average period of approximately 2.5 years and will be adjusted for subsequent changes in estimated forfeitures. We elected not to capitalize any stock-based compensation to inventory as of June 30, 2014 due to the immateriality of the amount.
 
We estimate the fair value of stock options using the Black-Scholes valuation model. There were 52,000 and zero stock options granted with weighted average grant date fair values of $1.10 and $0 in the three months ended June 30, 2014 and 2013, respectively. The fair value of our stock options granted to employees for the three and six months ended June 30, 2014 was estimated using the following weighted-average assumptions:

 
 
Three Months Ended
  
Six Months Ended
 
 
 
June 30, 2014
  
June 30, 2014
 
 
    
Expected term (in years)
  
4.0
   
4.0
 
Volatility
  
66.32
%
  
66.32
%
Expected dividend
  
0
%
  
0
%
Risk-free interest rate
  
1.98
%
  
1.98
%

The following table summarizes the stock option transactions during the six months ended June 30, 2014 (in thousands, except per share data):
 
Stock Options
 
Shares
  
Weighted-
average
Exercise
Price
  
Weighted-
average
Remaining
Contractual
Life
(in years)
  
Aggregate
Intrinsic
Value
 
 
 
  
  
  
 
Balance as of January 1, 2014
  
2,671
  
$
3.29
   
6.71
  
$
893
 
Granted
  
52
   
2.14
         
Exercised
  
(5
)
  
1.29
         
Canceled and expired
  
(73
)
  
5.18
         
Balance as of June 30, 2014
  
2,645
  
$
3.22
   
6.48
  
$
383
 
 
                
Options vested and expected to vest as of June 30, 2014
  
2,645
  
$
3.22
   
6.48
  
$
383
 
 
                
Options exercisable as of June 30, 2014
  
1,729
  
$
3.35
   
5.29
  
$
383
 
 
The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing price of $2.14 on June 30, 2014, which would have been received by the option holder had all option holders exercised their options on that date.
 
Restricted stock awards

A summary of activity related to restricted stock awards for the six months ended June 30, 2014 is presented below:

Stock Awards
 
Shares
  
Weighted-Average
Grant Date Fair Value
 
Non-vested as of January 1, 2014
  
241,232
  
$
3.44
 
Granted
  
55,044
  
$
2.18
 
Vested
  
(30,320
)
 
$
3.96
 
Non-vested as of June 30, 2014
  
265,956
  
$
3.12
 

As of June 30, 2014, the unamortized compensation costs related to unvested restricted stock awards was approximately $599,000, which is to be amortized on a straight-line basis over a weighted average period of approximately 1.4 years.